Co-Diagnostics Investor Relations Material

Co-Diagnostics, Inc. is a molecular diagnostics company that develops and manufactures diagnostic testing products. The company's core focus is on creating and commercializing molecular technologies that detect infectious diseases, as well as other genetic conditions. Co-Diagnostics utilizes its proprietary CoPrimer technology to design highly accurate and cost-effective diagnostic tests. The company serves the healthcare sector, offering its products to laboratories, hospitals, and healthcare providers globally, with applications in human diagnostics, agriculture, and animal testing. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.